Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- ChecktodayChange DetectedThe page’s revision label changed from v3.5.4 to v3.5.5, indicating a newer edition of the ClinicalTrials.gov record. This appears to be a minor update to the page rather than a substantive change to study details.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a small maintenance update to the page's revision history.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s display version rather than the underlying study record content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 to reflect the latest site version.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; a minor administrative update with no changes to study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.